Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin with Neo-adjuvant Chemotherapy in HER2+ Breast Cancer
NCT03238495Phase 2Unknown
- Sponsor
- Qamar Khan
- Start
- Aug 2017
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in HER2-positive breast cancer, sponsored by Qamar Khan. Status: unknown.
02
Drugs
metformin
03
Conditions
HER2-positive breast cancer
Beyond the preview
Go deeper on NCT03238495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03238495.